TECX's three largest insider shareholders as of April 28, 2026 are Timothy A Springer (Director, 5.84Mn shares), Braden Michael Leonard (TenPercentOwner, 4.77Mn shares), Geoffrey Mackay (President Ceo, 633.13K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Timothy A Springer | - | 4,334,846 | 1,503,358 | 11 Apr, 2025 |
| Braden Michael Leonard | - | 0 | 4,768,262 | 15 May, 2024 |
| Geoffrey Mackay | President Ceo | 188,012 | 445,123 | 26 Jan, 2023 |
| Terrance Mcguire | - | 0 | 573,062 | 07 Apr, 2025 |
| Alise Reicin | Chief Executive Officer | 311,547 | 127,030 | 05 Mar, 2026 |
| Braden Michael Leonard | - | 33,333 | 400,355 | 25 Jun, 2024 |
| Timothy A Springer | - | 0 | 186,134 | 26 Sep, 2024 |
| Christian Cortis | Chief Operating Officer | 126,368 | 0 | 24 Jun, 2024 |
| Marcella K. Ruddy | Chief Medical Officer | 68,747 | 0 | 03 Apr, 2026 |
| Daniel Lochner | Chief Financial Officer | 58,544 | 0 | 05 Mar, 2026 |
| Azadeh Golipour | Chief Technology Officer | 55,872 | 0 | 05 Feb, 2024 |
| Peter Mcnamara | Chief Scientific Officer | 55,285 | 0 | 09 Mar, 2026 |
| Marc Schwabish | Chief Business Officer | 45,314 | 0 | 05 Mar, 2026 |
| Erik Ostrowski | Interim Ceo, President And Cfo | 29,285 | 0 | 05 Feb, 2024 |
| Stefan Vitorovic | - | 0 | 27,774 | 24 Jun, 2024 |
| Steven Avruch | Chief Legal Officer | 22,022 | 0 | 05 Feb, 2024 |
| Essra Ridha | Chief Medical Officer | 15,881 | 0 | 05 Feb, 2024 |
| Philip J. Vickers | - | 4,800 | 0 | 08 Jul, 2021 |
| Praveen P. Tipirneni | - | 3,037 | 0 | 24 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Francois Nader | Stock Option (Right to Buy) | A | 20,400 | $0.00 | 20,400 | D | A |
| 01 Apr, 2026 | Marcella K. Ruddy | Common Stock | D | 1,000 | $31.05 | 68,747 | D | S |
| 06 Mar, 2026 | Marcella K. Ruddy | Common Stock | D | 10,000 | $30.00 | 69,747 | D | S |
| 06 Mar, 2026 | Peter Mcnamara | Common Stock | A | 2,500 | $2.38 | 61,332 | D | M |
| 06 Mar, 2026 | Peter Mcnamara | Common Stock | A | 215 | $14.71 | 61,547 | D | M |
| 06 Mar, 2026 | Peter Mcnamara | Common Stock | D | 6,047 | $30.00 | 55,500 | D | S |
| 06 Mar, 2026 | Peter Mcnamara | Common Stock | D | 215 | $35.00 | 55,285 | D | S |
| 06 Mar, 2026 | Peter Mcnamara | Employee Stock Option (Right to Buy) | D | 2,500 | - | 31,959 | D | M |
| 06 Mar, 2026 | Peter Mcnamara | Employee Stock Option (Right to Buy) | D | 215 | $0.00 | 8,045 | D | M |
| 04 Mar, 2026 | Marc Schwabish | Common Stock | A | 19,500 | $0.00 | 45,314 | D | A |
| 03 Mar, 2026 | Peter Mcnamara | Common Stock | D | 1,649 | $22.06 | 37,482 | D | S |
| 11 Feb, 2026 | Alise Reicin | Common Stock | A | 2,500 | $21.10 | 127,030 | I | P |
| 04 Mar, 2026 | Marcella K. Ruddy | Common Stock | A | 26,500 | $0.00 | 79,747 | D | A |
| 04 Mar, 2026 | Alise Reicin | Common Stock | A | 76,500 | $0.00 | 311,547 | D | A |
| 04 Mar, 2026 | Daniel Lochner | Common Stock | A | 26,500 | $0.00 | 58,544 | D | A |
| 04 Mar, 2026 | Peter Mcnamara | Common Stock | A | 23,000 | $0.00 | 60,482 | D | A |
| 04 Mar, 2026 | Marc Schwabish | Employee Stock Option (Right to Buy) | A | 17,750 | $0.00 | 17,750 | D | A |
| 04 Mar, 2026 | Daniel Lochner | Employee Stock Option (Right to Buy) | A | 24,250 | $0.00 | 24,250 | D | A |
| 04 Mar, 2026 | Marcella K. Ruddy | Employee Stock Option (Right to Buy) | A | 24,250 | $0.00 | 24,250 | D | A |
| 04 Mar, 2026 | Peter Mcnamara | Common Stock | D | 1,650 | $25.00 | 58,832 | D | S |